He maintains a robust translational research agenda, primarily focused on chronic limb-threatening ischemia; current projects include a study of mesenchymal stem cells in ischemic skeletal muscle, angiogenesis in ischemic limbs, tissue nanotransfection, and the healing of diabetic foot wounds.
